Vascular Access Devices Market Report 2026

Vascular Access Devices Market Overview

• Vascular Access Devices market size has reached to $6.11 billion in 2025 • Expected to grow to $8.38 billion in 2030 at a compound annual growth rate (CAGR) of 6.5% • Growth Driver: Lifestyle Diseases Fueling Growth in the Vascular Access Devices Market • Market Trend: Innovative Vascular Access Devices Revolutionize Care with TipTracker Technology • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Vascular Access Devices Market?

Vascular access devices (VADs) are medical devices that provide access to the bloodstream for a number of tasks, including giving drugs, administering fluids or blood products, or performing diagnostic tests. These devices are used to avoid the need for repeated needle punctures in patients, making it more convenient for both healthcare providers and patients. The main types of vascular access devices are central vascular access devices and peripheral vascular access devices. Central vascular access devices are medical devices designed for inserting catheters into larger veins, typically located near the body's center. They are used for various applications including drug administration, fluid and nutrition administration, blood transfusion, and diagnostics and testing by various end-users such as hospitals, clinics, ambulatory care centers, and others.

What Is The Vascular Access Devices Market Growth Forecast?

The vascular access devices market size is expected to see strong growth in the next few years. It will grow to $8.38 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to growing preference for minimally invasive and patient friendly venous access solutions, increasing adoption of implantable ports for oncology and long duration therapies, expansion of vascular access services in ambulatory care centers, rising procedural volumes in drug and nutrition administration, increasing investments in safer catheter designs to reduce complications. Major trends in the forecast period include rising clinical adoption of long-term vascular access devices for chronic disease management, increasing demand for vascular access products that reduce repeated needle punctures, growing utilization of specialized catheters for chemotherapy, infusion therapy, and blood administration, expanding procedural volumes in hospitals and ambulatory care centers requiring reliable venous access, increasing emphasis on product designs enhancing patient comfort and procedural safety.

Global Vascular Access Devices Market Segmentation

1) By Device Type: Central Vascular Access Devices, Peripheral Vascular Access Devices 2) By Application: Drug Administration, Fluid And Nutrition Administration, Blood Transfusion, Diagnostics And Testing 3) By End User: Hospitals, Clinics, Ambulatory Care Centers, Other End Users Subsegments: 1) By Central Vascular Access Devices: Central Venous Catheters (CVC), Peripherally Inserted Central Catheters (PICC), Implantable Ports 2) By Peripheral Vascular Access Devices: Peripheral IV Catheters, Midline Catheters, Butterfly Needles

What Is The Driver Of The Vascular Access Devices Market?

The growing prevalence of lifestyle diseases is expected to propel the growth of the vascular access devices market going forward. Lifestyle diseases, also known as non-communicable diseases (NCDs) or chronic diseases, are a group of health conditions that are primarily caused by unhealthy lifestyle choices and behaviors rather than infectious agents. These diseases often require ongoing treatment and care, making vascular access devices essential for the safe and effective delivery of medications and therapies. For instance, in July 2025, according to the International Diabetes Federation, a Brussels, Belgium-based international non-profit federation, approximately 589 million adults (20-79 years) are living with diabetes globally. By 2050, the total number of people living with diabetes is projected to rise to 853 million, representing an increase of 46% from current levels. Therefore, the growing prevalence of lifestyle diseases is driving the growth of the vascular access devices industry.

Key Players In The Global Vascular Access Devices Market

Major companies operating in the vascular access devices market are Medtronic plc, Fresenius Medical Care AG & Co. KGaA, Becton Dickinson and Company (BD), Baxter International Inc., Boston Scientific Corporation, Medline Industries LP, Terumo Corporation, B. Braun Melsungen AG, Teleflex Incorporated, ICU Medical Inc., Cook Medical, Merit Medical Systems Inc., AngioDynamics Inc., Argon Medical Devices Inc., Nipro Medical Corporation, pfm medical ag, Amecath Medical Technologies, Romsons Group, Medical Components Inc., Access Vascular Inc., Newtech Medical Devices Pvt. Ltd., Vygon USA

Global Vascular Access Devices Market Trends and Insights

Major companies operating in the vascular access devices market are increasing their focus on developing more efficient devices using advanced technologies such as TipTracker technology to gain a competitive edge in the market. The TipTracker Technology provides real-time visual navigation, tracing the catheter pathway on a color screen, and helps confirm final tip placement. For instance, in May 2023, Teleflex Incorporated, a US-based producer of medical devices, launched two new devices VPS Rhythm and DLX Device. This incorporates TipTracker technology, which eliminates the need for confirmatory X-rays, streamlining the peripherally inserted central catheter (PICC) insertion process. Additionally, this ensures enhanced PICC advancement into the superior vena cava (SVC) for successful insertion. The launch of the VPS Rhythm and DLX Device adds value by improving patient care, expanding treatment options, enhancing efficiency, and contributing to medical advancements.

What Are Latest Mergers And Acquisitions In The Vascular Access Devices Market?

In June 2025, Teleflex Incorporated, a US-based global provider of medical technologies, completed the acquisition of BIOTRONIK's Vascular Intervention business for approximately $791 million in cash. The acquisition aims to significantly enhance Teleflex's global presence in the catheterization lab, expand its suite of innovative vascular access and intervention technologies, and strengthen its position in peripheral vascular intervention procedures. BIOTRONIK's Vascular Intervention business is a Germany-based medical device division specializing in drug-coated balloons, drug-eluting stents, balloon catheters, and other vascular access and intervention technologies.

Regional Outlook

North America was the largest region in the vascular access devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Vascular Access Devices Market?

The vascular access devices market consists of sales of peripheral intravenous (IV) catheters, implanted ports, infusion pumps, ultrasound and X-ray equipment, and catheter removal kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.